CTI BioPharma Corp. (CTIC) - NASDAQ
From other sites
Company Description
CTI BioPharma Corp. operates as a biopharmaceutical company, which is focused on the acquisition, development, and commercialization novel targeted therapies covering a spectrum of blood-related cancers. Its products include Pixuvri, Pacritinib, Tosedostat and Opaxio. The company was founded by... More
Sector: Healthcare
Industry: Biotechnology
Country: United States